Daisuke Sueta
Kumamoto Health Science University(JP)Kumamoto University(JP)
Publications by Year
Research Areas
Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes, Cardiac Imaging and Diagnostics, Cardiovascular Function and Risk Factors, Acute Myocardial Infarction Research
Most-Cited Works
- → Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice(2014)416 cited
- → Accuracy of Cuff-Measured Blood Pressure(2017)260 cited
- → Perindopril, a centrally active angiotensin‐converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease(2011)140 cited
- → Attenuation of Brain Damage and Cognitive Impairment by Direct Renin Inhibition in Mice With Chronic Cerebral Hypoperfusion(2011)107 cited
- → Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction(2017)90 cited
- → Apoptosis Signal–Regulating Kinase 1 Is a Novel Target Molecule for Cognitive Impairment Induced by Chronic Cerebral Hypoperfusion(2013)88 cited
- → H2FPEF Score as a Prognostic Value in HFpEF Patients(2019)76 cited
- → Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) study(2017)74 cited
- → Validation of the high mortality rate of Malnutrition-Inflammation-Atherosclerosis syndrome(2016)72 cited
- → LCZ696, Angiotensin II Receptor-Neprilysin Inhibitor, Ameliorates High-Salt-Induced Hypertension and Cardiovascular Injury More Than Valsartan Alone(2015)72 cited